Join to View Full Profile
9600 Patterson AveRichmond, VA 23229
Phone+1 804-217-9601
Fax+1 804-217-9602
Dr. Patel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Adult and Pediatric Rheumatology in Richmond and Charlottesville.
Education & Training
Stony Brook Medicine/University HospitalResidency, Internal Medicine/Pediatrics, 2004 - 2008
Ross University School of MedicineClass of 2004
Certifications & Licensure
VA State Medical License 2012 - 2026
PA State Medical License 2008 - 2012
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Rheumatology
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Rheumatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- Recruitment rate comparison between a virtual tele-research cohort and a traditional centre-based cohort in idiopathic inflammatory myopathy.Siamak Moghadam-Kia, Anushka Aggarwal, Swamy Venuturupalli, Shiri Keret, Nantakarn Pongtarakulpanit
Rheumatology. 2025-08-01 - Characteristics of and risk factors for COVID-19 breakthrough infections in idiopathic inflammatory myopathies: results from the COVAD study.Leonardo Santos Hoff, Naveen Ravichandran, Parikshit Sen, Jessica Day, Mrudula Joshi
Rheumatology. 2025-02-01 - Reduced Health-Related Quality of Life in Patients With Systemic Sclerosis: A Cross-Sectional Analysis of PROMIS Global Health Data From the International COVAD-2 e-Su...Keina Yomono, Yuan Li, Vahed Maroufy, Naveen Ravichandran, Akira Yoshida
International Journal of Rheumatic Diseases. 2025-02-01
Press Mentions
FDA Extends Upadacitinib Indications to Children with ArthritisJune 5th, 2024- RINVOQ® (Upadacitinib) Now Available for Pediatric Patients Two Years and Older with Polyarticular Juvenile Idiopathic Arthritis and Psoriatic ArthritisJune 7th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
